Wat is de ideale concentratie van Ropivacaine bij Sufenta 0,75 microgram/ml voor Thoracale Epidurale?

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-001285-40-BE

Enrollment

150

Registered

2005-12-20

Start date

2004-10-25

Completion date

Unknown

Last updated

2014-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracotomy for lung resection

Interventions

Trade Name: Naropin Product Name: Naropin Pharmaceutical Form: Solution for infusion INN or Proposed INN: Ropivacaine CAS Number: 84057-95-4 Concentration unit: mg/ml milligram(s)/millilitre Concentra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Thoracotomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Contra-indications for thoracotomy

Design outcomes

Primary

Measure	Time frame
Main Objective: Determination of the ideal concentration of ropivacain together with Sufenta 0,75 microgram/ml for thoracal epidural analgesia.;Secondary Objective: ;Primary end point(s): VAS score (rest and dynamic) Sedation Pruritis Nausea Respiratory depression	—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026